Examining the level of awareness and attitudes towards gender-neutral HPV vaccination of the parents of children aged 9-18 years and adults: a qualitative research

Authors

DOI:

https://doi.org/10.18370/2309-4117.2024.75.8-16

Keywords:

human papilloma virus, HPV, cervical cancer prevention, HPV vaccination

Abstract

Objective of the study: to assess the awareness of human papilloma virus (HPV) infection and HPV-related diseases among the parents of children aged 9-18 years and adults, to determine the level of readiness to be vaccinated and to vaccinate their children against HPV; to identify existing barriers to this, and to explore how war affects perceptions of vaccination.
Materials and methods. A qualitative exploratory research was conducted. The data were collected through focus group discussions. Parents of children aged 9-18 and adults (men aged 18-26, women aged 18-45) took part in the research.
Results. Most respondents were aware of HPV infection and HPV-related diseases, adult women and parents of children aged 9-18 years were more aware than adult men. However, the level of knowledge was limited and generally insufficient.
The majority of respondents recognize HPV as a serious problem that leads to cancer, but the opinion that HPV is not a big problem was quite often expressed among adults and parents. Only a part of the interviewed women was informed about HPV by gynecologists, while men did not receive any data on this issue from health workers at all. The research revealed an extremely low level of awareness among adults and parents of children about the availability of HPV vaccination and its features. Adults and parents explained their ignorance in this matter by the fact that doctors mostly do not tell patients about this vaccine and do not recommend vaccination against HPV.
The vast majority of parents did not want to vaccinate their children against HPV due to the lack of information about its effectiveness and safety. But they were more likely to reconsider their decision after receiving more information about the vaccine. Less often, parents reported a potential willingness to vaccinate their child against HPV. Common barriers to vaccination are primarily related to doubts about vaccine safety, mistrust of the medical system and vaccine manufacturers, and lack of knowledge about how vaccines work, what they are made of, and how they affect the body. However, parents and adults overwhelmingly believe that their attitudes toward HPV vaccination will improve if free vaccination is introduced.
In the regions closest to hostilities (East, South) the situation with vaccination during the war worsened to a greater extent than in other regions. Most adults did not change their attitudes about vaccination during the war, and for a minority of them vaccination became less important. A third of parents reported that the relevance and importance of vaccination for them decreased, for a third it remained unchanged, and for another third it increased.
Conclusions. Widespread and insufficient awareness of HPV infection and HPV-related diseases among parents of children aged 9-18 years and adults. Adults and parents base their assumptions that HPV is not a serious problem on the lack of objective information from doctors, as well as in the mass media or social networks.
Most adults and parents of children aged 9-18 are not currently ready to vaccinate themselves or their children against HPV.
The war affected both access to vaccination and the perception of the relevance of vaccination, depending on the distance of the region of residence from the front line. Vaccination access decreased in regions near active hostilities, in small cities and rural areas.
Efforts are needed to increase awareness of HPV vaccination, including the importance of informing parents and adults about the HPV vaccine, timely vaccination, and regular screenings.

Author Biographies

T.F. Tatarchuk, SI «All-Ukrainian Center of Maternity and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, corresponding member of the National Academy of Medical Sciences of Ukraine, deputy director for scientific work, head of the Department of Endocrine Gynecology;
Chief researcher, Reproductive Health Department

Y.G. Antypkin, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine», Kyiv

MD, professor, academician of the National Academy of Medical Sciences of Ukraine, director

S.I. Regeda, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

PhD, senior researcher, Department of Endocrine Gynecology;
Head of the Gynecology Department

L.V. Kalugina, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, chief researcher, Department of Endocrine Gynecology;
Chief researcher, Department of Reproductive Health

T.M. Tutchenko, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, senior researcher, Department of Endocrine Gynecology;
Department of Reproductive Health

N.V. Kosei, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, chief researcher, Department of Endocrine Gynecology;
Head of the Reproductive Health Department

Y.V. Tatarchuk, P.L. Shupyk National University of Health Care of Ukraine, Kyiv

Graduate student, Department of Health Care Management

T.M. Povetkina, P.L. Shupyk National University of Health Care of Ukraine, Kyiv

PhD, associate professor, Department of Therapy and Geriatrics

References

  1. Okunade KS Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020 Jul;40(5):602–8. DOI: 10.1080/01443615.2019.1634030.
  2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. DOI: 10.3322/caac.21660
  3. Fedorenko Z, Gulak L, Gorokh Y, et al. Cancer in Ukraine, 2020–2021. Morbidity, mortality, prevalence and other relevant statistics. [Internet]. Bulletin of the National Cancer Registry of Ukraine. 2022 Vol 23 Available from: http://www.ncru.inf.ua/publications/index.htm
  4. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019;393(10167):169–182. DOI: 10.1016/S0140-6736(18)32470-X
  5. Athanasiou A, Bowden S, Paraskevaidi M, Fotopoulou C, et al. HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2020 May;65:109–124. DOI: 10.1016/j.bpobgyn.2020.02.009
  6. Kim J, Dove MS, Dang JHT. Sociodemographic factors associated with HPV awareness/knowledge and cervical cancer screening behaviors among caregivers in the US. BMC Womens Health. 2022;22(1):335. DOI: 10.1186/s12905-022-01918-4
  7. Venkatas J, Singh M. Cervical cancer: a meta-analysis, therapy and future of nanomedicine. Ecancermedicalscience. 2020;14:1111. DOI: 10.3332/ecancer.2020.1111
  8. Wilailak S, Kengsakul M, Kehoe S. Worldwide initiatives to eliminate cervical cancer. Int J Gynaecol Obstet. 2021;155 Suppl 1:102-106. DOI: 10.1002/ijgo.13879
  9. World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer As a Public Health Problem. [Internet]. WHO; 2020. Available from: https://www.who.int/publications/i/item/9789240014107
  10. Giannone G, Giuliano AR, Bandini M, et al. HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. 2022;111:102467. DOI: 10.1016/j.ctrv.2022.102467.
  11. World Health Organization. Guide to Introducing HPV Vaccine into National Immunization Programmes. WHO; 2016. Available from: https://www.who. int/publications/i/item/9789241549769
  12. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191-e203. DOI: 10.1016/S2214-109X(19)30482-6
  13. Ekwunife OI, O’Mahony JF, Gerber Grote A, at al. Challenges in cost-effectiveness analysis modelling of hpv vaccines in low- and middle-income countries: a systematic review and practice recommendations. Pharmacoeconomics. 2017;35:65–82. DOI: 10.1007/s40273-016-0451-7
  14. Hull R, Mbele M, Makhafola T, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20:2058–74. DOI: 10.3892/ol.2020.11754
  15. Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health. 2014;2:e406–e414. DOI: 10.1016/S2214-109X(14)70237-2.
  16. Luttjeboer J, Wondimu A, Van der Schans J, Postma MJ. Maximising the potential of HPV vaccines. Lancet Glob Health. 2020;8:e460–e461. DOI: 10.1016/S2214-109X(20)30073-5
  17. Holy O, Machaczka O, Schovankova T, et al. Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia. Front Public Health. 2024 May 15;12:1347800. DOI: 10.3389/fpubh.2024.1347800.
  18. Falcaro M, Castañon A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021:398:2084–92. DOI: 10.1016/S0140-6736(21)02178-4.
  19. Harder T, Wichmann O, Klug SJ, et al. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018:16:110. DOI: 10.1186/s12916-018-1098-3.
  20. Giannone G, Giuliano AR, Bandini M, et al. HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. 2022:111:102467. DOI: 10.1016/j.ctrv.2022.102467.
  21. World Health Organization. COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades. [Internet]. WHO. 2022. Available from: https://www.who.int/news/item/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades (Accessed February 15, 2023).
  22. Order of the Ministry of Health of Ukraine dated September 16, 2011 No. 595 with amendments «On the procedure for conducting prophylactic vaccinations in Ukraine and quality control and circulation of medical immunobiological medicinal products» [Internet]. МОЗ України. 2011. Available from: https://zakon.rada.gov. ua/laws/show/z1159-11#Текст
  23. Order of the Ministry of Health of Ukraine dated May 18, 2018 No. 947 «On Amendments to the Calendar of Preventive Vaccinations in Ukraine». [Internet]. МОЗ України. 2018. Available from: https://zakon.rada.gov.ua/laws/show/z0659-18 #Текст
  24. Order of the Ministry of Health of Ukraine dated June 3, 2022 No. 948 «On approval of the Methodology for calculating the need for medical immunobiological preparations (vaccines) and medical products used for preventive vaccinations» [Internet]. Ministry of Health of Ukraine. 2018. Available from: https:// zakon.rada. gov.ua/laws/show/z0664-18#Text
  25. Report of the SAGE Working Group on Vaccination Hesitancy. [Internet] [accessed on 10 April 2023]. Available from: https://www.asset-scienceinsociety.eu
  26. Zastawna B, Milewska A, Załuska R, et al. Analysis of Parents’ Attitudes and Knowledge toward Immunization and How These Factors Influence Their Decisions to Vaccinate Their Children against Human Papilloma Virus (HPV). Medicina (Kaunas). 2023 Sep 30;59(10):1755. DOI: 10.3390/medicina59101755.
  27. Fallucca A, Immordino P, Riggio L, et al. Acceptability of. HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines (Basel). 2022 Jun 22;10(7):998. DOI: 10.3390/vaccines10070998.
  28. Restivo V, Costantino C, Fazio TF, et al. Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation. Int J Environ Res Public Health. 2018 Apr 17;15(4):770. DOI: 10.3390/ijerph15040770.
  29. Mihretie GN, Liyeh TM, Ayele AD, et al. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross- sectional study. Reprod Health. 2022 Jun 10;19(1):136. DOI: 10.1186/s12978-022-01444-4.
  30. Akhatova A, Azizan A, Atageldiyeva K, et al. Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State. Vaccines (Basel). 2022 Nov 11;10(11):1912. DOI: 10.3390/vaccines10111912.
  31. Mendes Lobão W, Duarte FG, Burns JD, et al. Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery? PLoS One. 2018 Nov 12;13(11):e0206726. DOI:10.1371/journal.pone.0206726.
  32. Chernyshov PV, Humenna I. Human papillomavirus: vaccination, related cancer awareness, and risk of transmission among female medical students. Acta Dermatovenerol Alp Pannonica Adriat. 2019 Jun;28(2):75-79.
  33. Quinn V JM, Dhabalia TJ, Roslycky LL, et al. COVID-19 at War: The Joint Forces Operation in Ukraine. Disaster Med Public Health Prep. 2022 Oct;16(5):1753–60. DOI: 10.1017/dmp.2021.88.
  34. De Figueiredo A, Simas C, Karafillakis E, et al. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 2020; published online Sept 10. DOI: 10.1016/S0140-6736(20)31558-0.
  35. Hennink MM, Kaiser BN, Weber MB. What Influences Saturation? Estimating Sample Sizes in Focus Group Research. Qual Health Res. 2019 Aug;29(10):1483–96. DOI: 10.1177/1049732318821692
  36. Abuduxike G, Asut O, Cali S, Vaizoglu S. Knowledge and Awareness of Parents Towards Human Papillomavirus (HPV) and HPV Vaccines, and Vaccine Acceptability in Northern Cyprus. J Prev (2022). 2022 Apr;43(2):225–40. DOI: 10.1007/s10935-021-00657-w
  37. Tsakiroglou M, Bakalis M, Valasoulis G, et al. Women’s knowledge and utilization of gynecological cancer prevention services in the Northwest of Greece. Eur. J. Gynaecol. Oncol. 2011;32:178–81.
  38. Elissa, N., Charbel, H., Marly, A. et al. Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old. Reprod Health. 2024 Mar 27;21(1):40. DOI: 10.1186/s12978-024-01764-7.
  39. Smolarczyk K, Duszewska A, Drozd S, Majewski S. Parents’ knowledge and attiutude towards HPV and HPV vaccination in Poland. Vaccines. 2022;10:228. DOI: 10.3390/vaccines10020228.
  40. Zastawna B, Załuska R, Milewska A, et al. Protective Vaccination Used by Doctors for Prevention of Infections. Int. J. Environ. Res. Public Health. 2023;20:4153. DOI: 10.3390/ijerph20054153.
  41. Sussman AL, Helitzer D, Bennett A, et al. Catching Up With the HPV Vaccine: Challenges and Opportunities in Primary Care. Ann. Fam. Med. 2015;13:354–360. DOI: 10.1370/afm.1821.
  42. Stefanoff P, Sobierajski T, Bulinska-Stangrecka H, Augustynowicz E. Exploring factors improving support for vaccinations among Polish primary care physicians. PLoS ONE. 2022;15:e0232722. DOI: 10.1371/journal.pone.0232722.
  43. Spencer JP, Pawlowski RHT, Thomas S. Vaccine Adverse Events: Separating Myth from Reality. Am. Fam. Physician. 2017;95:786–794.
  44. Jamison AM, Quinn SC, Freimuth VS. You don’t trust a government vaccine: Narratives of institutional trust and influenza vaccination among African American and white adults. Soc. Sci. Med. 2019;221:87–94. DOI: 10.1016/j.socscimed.2018.12.020.
  45. Iova CF, Badau D, Daina MD, et al. Evaluation of the Knowledge and Attitude of Adolescents Regarding the HPV Infection, HPV Vaccination and Cervical Cancer in a Region from the Northwest of Romania. Patient Prefer. Adherence. 2023;17:2249–62. DOI: 10.2147/PPA.S421875.
  46. Kobayashi KI, Chanyasanha C, Sujirarat D. Parental decision-making on Human papillomavirus vaccination for daughters in Japan. Int. J. Adolesc. Med. Health. 2020;33:95–105. DOI: 10.1515/ijamh-2018-0140.
  47. Wemrell M, Gunnarsson L. Attitudes Toward HPV Vaccination in Sweden: A Survey Study. Front. Public Health. 2022;10:729497. DOI: 10.3389/fpubh.2022.729497.
  48. Siddiqui A, Abbas S, Qamar K, et al. COVID-19 Vaccine Hesitancy in Conflict Zones: A Review of Current Literature. Front Public Health. 2022 Dec 2:10:1006271.. DOI: 10.3389/fpubh.2022.1006271
  49. Osnytska Y, Lindsey M, Goodman A. Cervical Cancer Prevention Challenges and Barriers to Cervical Cancer Screening and HPV Vaccinations in Ukraine and Eastern Europe. Health. 2023. 15. 525–43. DOI: 10.4236/health.2023.156036
  50. Mohamad O, Zamlout A, AlKhoury N, et al. Factors Associated with the Intention of Syrian Adult Population to Accept COVID19 Vaccination: A Cross-Sectional Study. BMC Public Health 2021 ;21:1310. DOI: 10.1186/s12889-021-11361-z
  51. Hakimi S, Lami F, Allahqoli L, Alkatout I. Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review. J Turk Ger Gynecol Assoc. 2023 Mar 15;24(1):48–56. DOI: 10.4274/jtgga.galenos.2022.2022-6-6.

Downloads

Published

2024-12-31

How to Cite

Tatarchuk, T., Antypkin, Y., Regeda, S., Kalugina, L., Tutchenko, T., Kosei, N., Tatarchuk, Y., & Povetkina, T. (2024). Examining the level of awareness and attitudes towards gender-neutral HPV vaccination of the parents of children aged 9-18 years and adults: a qualitative research. REPRODUCTIVE ENDOCRINOLOGY, (75), 8–16. https://doi.org/10.18370/2309-4117.2024.75.8-16

Issue

No. 75 (2024)

Section

Статті

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.